These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12713763)
1. Combined lipid lowering drug therapy for the effective treatment of hypercholesterolaemia. Shepherd J Eur Heart J; 2003 Apr; 24(8):685-9. PubMed ID: 12713763 [No Abstract] [Full Text] [Related]
2. Intestinal sterol transporters and cholesterol absorption inhibition. Davis HR; Tershakovec AM; Tomassini JE; Musliner T Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558 [TBL] [Abstract][Full Text] [Related]
3. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption. Bruckert E; Giral P; Tellier P Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406 [No Abstract] [Full Text] [Related]
4. [Ezetimibe (Ezetrol)]. Scheen AJ Rev Med Liege; 2004 Apr; 59(4):246-50. PubMed ID: 15182038 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia. Sudhop T; von Bergmann K Drugs; 2002; 62(16):2333-47. PubMed ID: 12396226 [TBL] [Abstract][Full Text] [Related]
8. New concepts of mechanisms of intestinal cholesterol absorption. Wang DQ Ann Hepatol; 2003; 2(3):113-21. PubMed ID: 15115962 [TBL] [Abstract][Full Text] [Related]
9. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment. Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016 [TBL] [Abstract][Full Text] [Related]
10. [A new approach to the treatment of dyslipidemia]. Kevelaitiene S; Slapikas R Medicina (Kaunas); 2008; 44(5):407-13. PubMed ID: 18541958 [TBL] [Abstract][Full Text] [Related]
12. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men. Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E; J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343 [TBL] [Abstract][Full Text] [Related]
13. Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today? Descamps OS; De Sutter J; Guillaume M; Missault L Atherosclerosis; 2011 Aug; 217(2):308-21. PubMed ID: 21762916 [TBL] [Abstract][Full Text] [Related]
14. Ezetimibe in hypercholesterolaemia. Farnier M Int J Clin Pract; 2002 Oct; 56(8):611-4. PubMed ID: 12425372 [TBL] [Abstract][Full Text] [Related]
15. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption]. Márk L; Paragh G Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635 [TBL] [Abstract][Full Text] [Related]
16. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS; Mikhailidis DP Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [TBL] [Abstract][Full Text] [Related]
17. [Ezetimibe: from pharmacology to clinical trials]. Tellier P Ann Endocrinol (Paris); 2003 Dec; 64(6):442-7. PubMed ID: 15067249 [TBL] [Abstract][Full Text] [Related]
18. Ezetimibe/Simvastatin: a review of its use in the management of hypercholesterolemia. Murdoch D; Scott LJ Am J Cardiovasc Drugs; 2004; 4(6):405-22. PubMed ID: 15554726 [TBL] [Abstract][Full Text] [Related]
19. [After bypass surgery nearly all lipids are in the normal range. However, Lp(a) is too high, what can be done?]. Parhofer KG MMW Fortschr Med; 2011 May; 153(21):22. PubMed ID: 21736061 [No Abstract] [Full Text] [Related]
20. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects. Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]